Oral therapy admilparant slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF) in a Phase 3 ...

Cold and flu season can be stressful with PF, so columnist Kylene Henderson plans ahead so her family can still enjoy the ...

Columnist Ann Reynoso pays tribute to a special respiratory therapist who guided her during her pulmonary rehabilitation ...

Columnist Sam Kirton recalls some of the scariest moments since his IPF diagnosis, and invites readers to share their own experiences.

Columnist Sam Kirton's birthday prompts reflection on his IPF and transplant journey. Like Phil Collins, he says, "Take a look at me now." ...

Computer-based analyses of CT scans may help predict disease progression and track treatment response among people with PPF, per trial data.

Taking oral dietary supplements of epigallocatechin-3-gallate (EGCG) — an antioxidant in green tea — may stop and reverse the pro-fibrotic (scarring) state of the lungs of people with idiopathic ...

The Phase 3 REBUILD clinical trial, which tested Bellerophon Therapeutics‘ inhaled nitric oxide therapy INOpulse in people with pulmonary fibrosis at risk of developing pulmonary hypertension, failed ...

There is currently no cure for pulmonary fibrosis (PF). However, medication and other treatment options can help improve patients’ quality of life, ease symptoms, and slow the disease’s progression.

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to BMS-986278, Bristol Myers Squibb’s investigational therapy for progressive pulmonary fibrosis (PF).